Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Double-Blind Randomized Placebo-Controlled Trial of RUTI Therapeutic Vaccination in Multidrug-Resistant Tuberculosis
2016-000850-36Phase 2Active
- Sponsor
- Archivel Farma
- Start
- Oct 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Tuberculosis (TB) comparing RUTI therapeutic vaccine with Placebo (2 arms). Primary endpoint: Primary endpoint - Safety. Started Oct 2016; status: active.
02
Drugs
RUTI vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on 2016-000850-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000850-36.